Biography and Research Information
OverviewAI-generated summary
Mary Beth Littrell's research focuses on understanding factors that contribute to poorer outcomes in adolescents and young adults diagnosed with cancer. Her work has investigated specific types of tumors, including central nervous system embryonal tumors. A recent publication examined the reclassification of these tumors at relapse, particularly those with EWSR1-PLAGL1 rearrangements, identifying them as INI-1 deficient tumors upon recurrence.
Littrell has authored four publications with a total of 27 citations, and her h-index is 2. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Kevin Bielamowicz, Murat Gökden, Gregory W. Albert, and Sateesh Jayappa.
Metrics
- h-index: 2
- Publications: 4
- Citations: 27
Selected Publications
-
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse (2024)
Collaboration Network
Top Collaborators
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
- Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
Similar Researchers
Based on overlapping research topics